Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial

Gelijkaardige items

• A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ADDERALL AND METHYLPHENIDATE IN THE TREATMENT OF ATTENTION-DEFICIT / HYPERACTIVITY DISORDER
  door: PLISZKA, S.R
• OROS-METHYLPHENIDATE OR PLACEBO FOR ADULT SMOKERS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER: RACIAL/ETHNIC DIFFERENCES
  door: COVEY, L.S
• BUPROPION VERSUS METHYLPHENIDATE IN THE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER
  door: BARRICKMAN, L.L
• A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder
  door: McRae-Clark, A.L
• PREDICTION OF CLINICAL RESPONSE TO METHYLPHENIDATE IN CHILDREN WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER
  door: BUITELAAR, J.K